Over-prescription of short-acting β₂-agonists and asthma management in the Gulf region: a multicountry observational study.

ABSTRACT:

Background

The overuse of short-acting β₂-agonists (SABA) is associated with poor asthma control. However, data on SABA use in the Gulf region are limited. Herein, we describe SABA prescription practices and clinical outcomes in patients with asthma from the Gulf cohort of the SABA use IN Asthma (SABINA) III study.

Methods

In this cross-sectional study conducted at 16 sites across Kuwait, Oman, and the United Arab Emirates, eligible patients (aged ≥ 12 years) with asthma were classified based on investigator-defined disease severity guided by the 2017 Global Initiative for Asthma report and by practice type, i.e., respiratory specialist or primary care physician. Data on demographics, disease characteristics, and prescribed asthma treatments, including SABA, in th

SUBMITTER: Alzaabi A 

PROVIDER: S-EPMC9260980 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature